{Reference Type}: Journal Article
{Title}: Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells.
{Author}: Zhang H;Wu JC;
{Journal}: Adv Exp Med Biol
{Volume}: 1441
{Issue}: 0
{Year}: 2024
{Factor}: 3.65
{DOI}: 10.1007/978-3-031-44087-8_13
{Abstract}: Congenital heart disease (CHD) is a leading cause of birth defect-related death. Despite significant advances, the mechanisms underlying the development of CHD are complex and remain elusive due to a lack of efficient, reproducible, and translational model systems. Investigations relied on animal models have inherent limitations due to interspecies differences. Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for disease modeling. iPSCs allow for the production of a limitless supply of patient-specific somatic cells that enable advancement in cardiovascular precision medicine. Over the past decade, researchers have developed protocols to differentiate iPSCs to multiple cardiovascular lineages, as well as to enhance the maturity and functionality of these cells. With the development of physiologic three-dimensional cardiac organoids, iPSCs represent a powerful platform to mechanistically dissect CHD and serve as a foundation for future translational research.